Irish Pharmaceutical Healthcare Association (IPHA) - the IPHA represents the international research-based pharmaceutical industry in Ireland

Latest News

Archive | RSS

Lower price of medicines may save Irish patients up to €500 per year(02/01/2010): The Irish Pharmaceutical Healthcare Association (IPHA) announced that with effect from today, the 1st February 2010, the cost of long established medicines would be reduced by 40%. IPHA, the representative body for the international research-based pharmaceutical industry in Ireland, has set up a special website on which patients can check to see if their medicines are listed, and the price reduction. The website – www.checkthelist.ie - carries a detailed list of all the medicines and their new, lower prices. A lo-call number – (1890) 876 700 – has also been set up. checkthelist.ie includes some of the most commonly prescribed medicines in the country.
EVM Contributes to Council of Europe Hearing on “The Handling of The H1N1 Pandemic: More Transparency Needed?”(01/26/2010): European Vaccine Manufacturers (EVM) welcomed the opportunity to address today’s Council of Europe Health Committee hearing on ‘The handling of the H1N1 pandemic: more transparency needed?’ EVM was pleased to provide information on industry’s role in helping combat pandemic influenza, and sought to address many of the misunderstandings that exist regarding the pandemic planning process. The EVM rejected allegations of inappropriate behaviour by vaccine producers during the response to H1N1 influenza, and provided additional clarity in several key areas.
Industry Statement to WHO Executive Board on Pandemic Influenza Preparedness(01/20/2010): Years of research and development and over $4 billion of investment by influenza vaccine manufacturers, working closely with the WHO network, have led to the production of new and specifically tailored H1N1 vaccines, with the first regulatory approvals achieved only 3 months after the WHO’s pandemic declaration.